France Sleep Apnea Devices Market Outlook

the french sleep apnea devices market is looking at a promising outlook for the period 2018 – 2032. it is expected to have a significant impact in terms of healthcare costs, quality of life and improved overall public health. this is mainly due to the increased knowledge about sleep apnea and its consequences among the general public, health professionals and the government. in france, the most commonly used device for detection and diagnosis of sleep apnea is the polysomnogram (psg). psgis a non-invasive diagnostic study which allows the identification of the apnea-hypopnea index (ahi), the severity of sleep apnea and the decisions for the appropriate therapy. in recent times, an increased number of psg tests are being prescribed to diagnose sleep apnea, which is forcing the medical device companies to focus on new technologies and innovation and expansion of their product portfolio for offering devices tailored for individual needs. furthermore, there is an impetus on the adoption of home-based sleep apnea testing, rather than relying on costly clinical visits which has the potential to increase diagnosis and treatment and reduce costs. with increasing awareness about the importance of proper sleep and its associated health risks, french consumers are gravitating more towards evidenced-based sleep technologies. in addition to this, the french government is proactively pursuing steps to improve sleep health of the public by providing patient education on the risk factors of sleep disorders and relevant treatments, providing reimbursement for the prescribed sleep apnea diagnosis and treatment, supporting research and innovation and creating awareness programs. the french sleep apnea devices market is expected to benefit from the various initiatives taken by the government, as well as the significant investments in technological advancements, development and expansion of innovative sleep apnea products, and increased consumer focus on therapeutic modalities. so, overall, this market has a positive outlook for the period 2018-2032.